Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03838445Not ApplicableRecruiting

Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH)

Role: lead

NCT03499236Not ApplicableActive Not Recruiting

Reducing Lung CongestIon Symptoms in Advanced Heart Failure

Role: lead

NCT04729933Not ApplicableActive Not Recruiting

Implantation of a Permanent Interatrial Shunt to Reduce Left Atrial Filling Pressures Following MitraClip

Role: collaborator

NCT02511912Not ApplicableWithdrawn

Heart Failure (HF) Interatrial Shunt Study 1

Role: lead

NCT01965015Not ApplicableCompleted

The V-Wave Shunt: FIM Safety and Feasibility Study

Role: lead

All 5 trials loaded